Companies researching Opdivo (nivolumab)
Opdivo, known generically as nivolumab, is an immunotherapy medication employed to treat multiple forms of cancer.
26
companies
List of companies that research Opdivo (nivolumab)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
Employees39kRevenue$46BPharmaceutical ManufacturingOpdivo (nivolumab)Medium confidence
Employees3.7kRevenue$15MPharmaceutical ManufacturingOpdivo (nivolumab)Low confidence
Employees1.3kBusiness Consulting and ServicesOpdivo (nivolumab)Low confidence
Employees1.5kHospitals and Health CareOpdivo (nivolumab)Low confidence- Employees97Revenue$18MBusiness Consulting and ServicesOpdivo (nivolumab)Low confidence
Employees21kRevenue$5.5BHospitals and Health CareOpdivo (nivolumab)Low confidence
Employees1kRevenue$3.1MReal EstateOpdivo (nivolumab)Low confidence- Employees96Non-profit OrganizationsOpdivo (nivolumab)Low confidence
Employees201Revenue$36MMedical PracticesOpdivo (nivolumab)Low confidence
Employees33kPharmaceutical ManufacturingOpdivo (nivolumab)Low confidence
Showing top companies out of 26 that research Opdivo (nivolumab). Get the full list on TheirStack.
Frequently asked questions